Kevin Shelton, MD, and his co-conspirators allegedly intended to distribute controlled substances, including hydrocodone, oxandrolone, nandrolone, phentermine, alprazolam, diazepam, testosterone, tramadol, Adderall and dextroamphetamine, according to a Feb. 29 news release from the Justice Department.
The defendants are also accused of conspiring to commit the offense of money laundering.
Dr. Shelton was charged with conspiracy to possess with intent to manufacture and distribute controlled substances and conspiracy to commit money laundering.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.